Indiana intellectual property attorneys had first-hand experience with the increase of patent filings during the pandemic, as researchers and inventors harnessed their creative skills while quarantining.
More and more of the work done by university researchers is being spun off into companies and commercial applications that they or the universities own or are a part of.
At issue in the five-year legal dispute was whether Dr. Rick Sasso was properly compensated for various inventions, and whether Minnesota-based Medtronic paid him sufficient royalties as spelled out in their agreements.
Britain's Supreme Court has ruled in favor of Eli Lilly and Co. in a patent dispute with generic drugmaker Actavis over Lilly's Alimta cancer treatment.
Patent owners have seen massive erosion of their rights coupled with a rise in basic enforcement costs and risks.
The justices ruled unanimously Monday that patent infringement lawsuits can be filed only in states where defendants are incorporated. The case was sparked by an appeal from Carmel-based TC Heartland LLC.
The justices Monday heard arguments in a case involving Carmel-based flavoring maker TC Heartland that could end the reign of the Eastern District of Texas, which handles more than a third of all patent suits in the United States.
A unanimous Supreme Court on Tuesday sided with smartphone maker Samsung in its high-profile patent dispute with Apple over the design of the iPhone.
A center that helps Indiana University researchers commercialize their discoveries has moved its operations to be closer to faculty, industry and research partners.
Indianapolis-based Interactive Intelligence Inc. has filed a federal patent lawsuit against Avaya Inc., a competitor with which Interactive Intelligence also had a long-standing patent license agreement.
A professor in the Indiana School of Medicine is hopeful that an antibiotic cocktail he invented will one day improve the lives of millions of people, thanks in part to the Indiana University Research and Technology Corp., formed in 1997 to make work done by IU faculty and researchers available for commercial development.
Eli Lilly and Co. won a court ruling that will keep generic versions of the chemotherapy drug Alimta off the U.S. market until a patent expires in 2022.
The award is actually less than a third of what Warsaw-based Zimmer was originally ordered to pay for infringing patents on a lavage device.
“Troll” is a term without clear definition and yet it’s being used to push Congress and the Supreme Court to curb abusive litigation. Companies including Eli Lilly warn against damaging a centuries-old system designed to promote advances in science and industry.
Paris-based Sanofi sued Eli Lilly and Co. on Thursday for patent infringement. That suit triggers an automatic 30-month delay on Lilly’s plans to launch a similar version of Sanofi’s once-a-day insulin Lantus.
The suit, filed in January 2012 by South African-based Bayer CropScience SA, charged that Dow Agro’s Enlist E3 soybean seed infringed one of its patents.
Indiana-based Zimmer Holdings Inc., which lost a February trial against Stryker Corp. over a surgical device patent, was told to pay three times the jury award, plus other costs.